Not applicableLooking for participantsNCT06487247What this trial is testingHEME Home Transfusion ProgramWho this might be right forLeukemiaMyelomaMyelodysplastic Syndromes+3 more Dana-Farber Cancer Institute 700
Not applicableLooking for participantsNCT06999954What this trial is testingShwachman-Diamond Syndrome Global Patient Survey and Partnering PlatformWho this might be right forShwachman-Diamond SyndromeSDSIBMF+24 more Shwachman-Diamond Syndrome Alliance Inc 8,000
Not applicableLooking for participantsNCT05556928What this trial is testingCancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme RegistryWho this might be right forMultiple MyelomaAmyloidosisPlasma Cell Leukemia University of Alabama at Birmingham 5,000
Not applicableStudy completedNCT05509439What this trial is testingHome Transfusion for HEMEWho this might be right forHematologic Malignancy Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)Looking for participantsNCT05735717What this trial is testingMT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesWho this might be right forHematologic MalignancyAcute LeukemiaRemission+21 more Masonic Cancer Center, University of Minnesota 70
Not applicableStudy completedNCT03778606What this trial is testingOligosaccharide for Cdiff(+) Heme-onc PatientsWho this might be right forClostridium DifficileHematologic Diseases Medical College of Wisconsin 8
Not applicableLooking for participantsNCT06681818What this trial is testingNovel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyWho this might be right forLiver Cancer AdultLiver Regeneration Englewood Hospital and Medical Center 125
Large-scale testing (Phase 3)Looking for participantsNCT07504458What this trial is testingPivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaWho this might be right forAcute Promyelocytic Leukemia (APL)Acute Promyelocytic LeukaemiaAcute Promyelocytic Leukemia With PML-RARA+2 more Quetzal Therapeutics 150
Testing effectiveness (Phase 2)Looking for participantsNCT07214688What this trial is testingFludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme MalignanciesWho this might be right forAllogeneic Stem Cell Transplant Recipient Hackensack Meridian Health 209
Not applicableStudy completedNCT04195438What this trial is testingPostoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyWho this might be right forLiver Cancer University of Maryland, Baltimore 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03642626What this trial is testingMT2017-45: CAR-T Cell Therapy for Heme MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaLarge B-cell Lymphoma Masonic Cancer Center, University of Minnesota 150
Not applicableStudy completedNCT04690205What this trial is testingHospital at Home at EOL in Heme MalignanciesWho this might be right forHematologic Malignancy Massachusetts General Hospital 72
Early research (Phase 1)Study completedNCT00477542What this trial is testingA Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCTWho this might be right forHematologic Malignancies Indiana University School of Medicine 18
Not applicableEnded earlyNCT03955276What this trial is testingAn Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)Who this might be right forHematologic Cancer University of California, San Diego 13
Testing effectiveness (Phase 2)WithdrawnNCT02765997What this trial is testingStemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+1 more Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Looking for participantsNCT03314974What this trial is testingMyeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersWho this might be right forAcute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more Masonic Cancer Center, University of Minnesota 300
Testing effectiveness (Phase 2)Ended earlyNCT02991898What this trial is testingAdoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more Masonic Cancer Center, University of Minnesota 3